About Me
Adriana Rossi, MD, is Assistant Professor of Medicine (Hematology and Medical Oncology) and Co-director, CAR T and Stem Cell Transplant at the Center of Excellence for Multiple Myeloma. Dr. Rossi has extensive experience treating patients with multiple myeloma and related diseases, and has special expertise in cellular therapy. Prior to joining Mount Sinai in 2021, Dr. Rossi was Associate Clinical Director of the Myeloma Center at Weill Cornell, where she also served as the physician lead for cellular therapy in multiple myeloma.
Language
English, Italian, French, Portuguese, SpanishPosition
ASSISTANT PROFESSOR | Medicine, Hematology and Medical OncologyHospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
Adriana Rossi, MD, is Assistant Professor of Medicine (Hematology and Medical Oncology) and Co-director, CAR T and Stem Cell Transplant at the Center of Excellence for Multiple Myeloma. Dr. Rossi has extensive experience treating patients with multiple myeloma and related diseases, and has special expertise in cellular therapy. Prior to joining Mount Sinai in 2021, Dr. Rossi was Associate Clinical Director of the Myeloma Center at Weill Cornell, where she also served as the physician lead for cellular therapy in multiple myeloma.
Language
English, Italian, French, Portuguese, SpanishPosition
ASSISTANT PROFESSOR | Medicine, Hematology and Medical OncologyHospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
Adriana Rossi, MD, is Assistant Professor of Medicine (Hematology and Medical Oncology) and Co-director, CAR T and Stem Cell Transplant at the Center of Excellence for Multiple Myeloma. Dr. Rossi has extensive experience treating patients with multiple myeloma and related diseases, and has special expertise in cellular therapy. Prior to joining Mount Sinai in 2021, Dr. Rossi was Associate Clinical Director of the Myeloma Center at Weill Cornell, where she also served as the physician lead for cellular therapy in multiple myeloma.
Language
English, Italian, French, Portuguese, SpanishPosition
ASSISTANT PROFESSOR | Medicine, Hematology and Medical OncologyHospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Education
MD, George Washington University
Fellowship, Hematology & Oncology
New York Presbyterian Hospital-Weill Cornell Center
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Rossi did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Doctors
Accepting New Patients
